journal article·2024-04Open access

Machine learning-based approach for automated classification of cell and extracellular matrix using nanomechanical properties

Tanmay Kulkarni, Olivia-Marie Robinson, Ayan Dutta, Debabrata Mukhopadhyay, Santanu Bhattacharya

Abstract

Fibrosis characterized by excess accumulation of extracellular matrix (ECM) due to complex cell-ECM interactions plays a pivotal role in pathogenesis. Herein, we employ the pancreatic ductal adenocarcinoma (PDAC) model to investigate dynamic alterations in nanomechanical attributes arising from the cell-ECM interactions to study the fibrosis paradigm. Several segregated studies performed on cellular and ECM components fail to recapitulate their complex collaboration. We utilized collagen and fibronectin, the two most abundant PDAC ECM components, and studied their nanomechanical attributes. We demonstrate alteration in morphology and nanomechanical attributes of collagen with varying thicknesses of collagen gel. Furthermore, by mixing collagen and fibronectin in various stoichiometry, their nanomechanical attributes were observed to vary. To demonstrate the dynamicity and complexity of cell-ECM, we utilized Panc-1 and AsPC-1 cells with or without collagen. We observed that Panc-1 and AsPC-1 cells interact differently with collagen and vice versa, evident from their alteration in nanomechanical properties. Further, using nanomechanics data, we demonstrate that ML-based techniques were able to classify between ECM as well as cell, and cell subtypes in the presence/absence of collagen with higher accuracy. This work demonstrates a promising avenue to explore other ECM components facilitating deeper insights into tumor microenvironment and fibrosis paradigm.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cellular Mechanics and Interactions · 3D Printing in Biomedical Research · Cancer Cells and Metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (76)

Show source-provided references
1. Pathogenesis of liver cirrhosis10.3748/wjg.v20.i23.7312 ↗
2. Mechanisms of pulmonary fibrosis10.1146/annurev.med.55.091902.103810 ↗
3. Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration10.1007/s00441-016-2431-9 ↗
4. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival10.1016/j.ccr.2014.04.005 ↗
5. The myofibroblast in wound healing and fibrocontractive diseases10.1002/path.1427 ↗
6. Extracellular matrix as a driver of progressive fibrosis10.1172/JCI93557 ↗
7. Mechanisms of fibrosis: therapeutic translation for fibrotic disease10.1038/nm.2807 ↗
8. Fibroblasts in cancer10.1038/nrc1877 ↗
9. Desmoplasia in primary tumors and metastatic lesions of pancreatic cancerfibrosis in pancreatic metastases10.1158/1078-0432.CCR-14-1051 ↗
10. The tumour microenvironment in pancreatic cancer—clinical challenges and opportunities10.1038/s41571-020-0363-5 ↗
11. Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications10.1038/s41401-020-00584-2 ↗
12. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma10.1186/s13045-020-00958-3 ↗
13. Drugs in preclinical and early-stage clinical development for pancreatic cancer10.1517/13543784.2012.651124 ↗
14. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer10.1038/nature16064 ↗
15. Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma10.1245/ASO.2004.05.012 ↗
16. Metastasis-related processes show various degrees of activation in different stages of pancreatic cancer rat liver metastasis10.1159/000365496 ↗
17. The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview10.20892/j.issn.2095-3941.2019.0252 ↗
18. The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential10.1016/j.bbcan.2020.188423 ↗
19. Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis10.1158/0008-5472.CAN-06-2387 ↗
20. Pancreatic stellate cell models for transcriptional studies of desmoplasia-associated genes10.1159/000320540 ↗
21. Desmoplasia of pancreatic ductal adenocarcinoma10.1016/j.cgh.2009.07.039 ↗
22. Pancreatic stellate cells: a starring role in normal and diseased pancreas10.3389/fphys.2012.00344 ↗
23. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma10.1016/j.ccr.2014.04.021 ↗
24. Stromal response to Hedgehog signaling restrains pancreatic cancer progression10.1073/pnas.1411679111 ↗
25. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
26. Improving drug delivery to solid tumors: priming the tumor microenvironment10.1016/j.jconrel.2014.12.018 ↗
27. Acidity-triggered ligand-presenting nanoparticles to overcome sequential drug delivery barriers to tumors10.1021/acs.nanolett.7b02031 ↗
28. Strategies to increase drug penetration in solid tumors10.3389/fonc.2013.00193 ↗
29. Oncolytic virotherapy for pancreatic ductal adenocarcinoma: a glimmer of hope after years of disappointment?10.1016/j.cytogfr.2020.07.015 ↗
30. Challenges and future perspectives of immunotherapy in pancreatic cancer10.3390/cancers13164235 ↗
31. Trials and tribulations of pancreatic cancer immunotherapy10.1016/j.canlet.2021.01.031 ↗
32. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells10.1053/j.gastro.2004.12.036 ↗
33. Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells10.1073/pnas.1908626116 ↗
34. Establishment of a human 3D pancreatic adenocarcinoma model based on a patient-derived extracellular matrix scaffold10.1016/j.trsl.2022.08.015 ↗
35. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression10.1038/nm.4082 ↗
36. A glitch in the matrix: organ-specific matrisomes in metastatic niches10.1016/j.tcb.2021.08.001 ↗
37. Raman scattering of collagen, gelatin, and elastin10.1002/bip.1975.360140211 ↗
38. Influence of surface moieties on nanomechanical properties of gold nanoparticles using atomic force microscopy10.1016/j.apsusc.2022.153175 ↗
39. AFM study: cell cycle and probe geometry influences nanomechanical characterization of Panc1 cells10.1016/j.bbagen.2019.02.006 ↗
40. Sain · 1996
41. Vapnik · 1999
42. Subclinical elastofibromas in the scapular region in an autopsy series. Additional notes on the aetiology and pathogenesis of elastofibroma pseudoneoplasm
43. Collagen concentration and rates of synthesis in idiopathic pulmonary fibrosis
44. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach10.1002/path.2482 ↗
45. Fibronectin-containing hyaline globules in malignant melanoma10.1097/00000372-198501001-00007 ↗
46. Periodic beaded-filament assembly of fibronectin on negatively charged surface10.1016/j.jsb.2010.01.009 ↗
47. Tumor–stroma cross-talk in human pancreatic ductal adenocarcinoma: a focus on the effect of the extracellular matrix on tumor cell phenotype and invasive potential10.3390/cells7100158 ↗
48. Stellate cells aid growth-permissive metabolic reprogramming and promote gemcitabine chemoresistance in pancreatic cancer10.3390/cancers13040601 ↗
49. The matrix reloaded—the role of the extracellular matrix in cancer10.3390/cancers15072057 ↗
50. Targeting tumor-stromal interactions in pancreatic cancer: impact of collagens and mechanical traits10.3389/fcell.2021.787485 ↗
51. Influence of fibronectin on the fibrillogenesis of type I and type III collagen10.1016/S0174-173X(87)80003-1 ↗
52. Cancer associated fibroblasts: is the force the path to the dark side?10.1016/j.ceb.2018.09.002 ↗
53. Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions10.1016/j.ceb.2016.05.002 ↗
54. In vitro strategies for mimicking dynamic cell–ECM reciprocity in 3D culture models10.3389/fbioe.2023.1197075 ↗
55. Dynamic interplay between the collagen scaffold and tumor evolution10.1016/j.ceb.2010.08.015 ↗
56. Self-assembly of mesoscale collagen architectures and applications in 3D cell migration10.1016/j.actbio.2022.11.011 ↗
57. Tunable mesoscopic collagen island architectures modulate stem cell behavior
58. Nanomechanical analysis of extracellular matrix and cells in multicellular spheroids10.1007/s12195-019-00577-0 ↗
59. Impact of crosslink heterogeneity on extracellular matrix mechanics and remodeling10.1016/j.csbj.2020.11.038 ↗
60. Measuring the elastic properties of biological samples with the AFM10.1109/51.582176 ↗
61. Toward high-contrast atomic force microscopy-tip-enhanced Raman spectroscopy imaging: nanoantenna-mediated remote-excitation on sharp-tip silver nanowire probes10.1021/acs.nanolett.8b03399 ↗
62. Nanomechanical insight of pancreatic cancer cell membrane during receptor mediated endocytosis of targeted gold nanoparticles10.1021/acsabm.0c01443 ↗
63. Nanomechanical insights: amyloid beta oligomer-induced senescent brain endothelial cells10.1016/j.bbamem.2019.183061 ↗
64. Structural investigations on native collagen type I fibrils using AFM10.1016/j.bbrc.2006.12.114 ↗
65. Atomic force microscopy for collagen-based nanobiomaterials10.1155/2017/9234627 ↗
66. The mechanical hierarchies of fibronectin observed with single-molecule AFM10.1016/S0022-2836(02)00306-6 ↗
67. Molecular-scale topographic cues induce the orientation and directional movement of fibroblasts on two-dimensional collagen surfaces10.1016/j.jmb.2005.03.064 ↗
68. Cellular remodelling of individual collagen fibrils visualized by time-lapse AFM10.1016/j.jmb.2007.06.078 ↗
69. Quantification of fibronectin and cell surface interactions by AFM10.1016/S0927-7765(01)00299-5 ↗
70. Machine learning identifies robust matrisome markers and regulatory mechanisms in cancer10.3390/ijms21228837 ↗
71. Self-supervised classification of subcellular morphometric phenotypes reveals extracellular matrix-specific morphological responses10.1038/s41598-022-19472-2 ↗
72. Application of self-organizing maps to AFM-based viscoelastic characterization of breast cancer cell mechanics10.1038/s41598-023-30156-3 ↗
73. AFM assessing of nanomechanical fingerprints for cancer early diagnosis and classification: from single cell to tissue level10.1039/C8NR06146G ↗
74. Constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning10.1186/s12890-023-02699-8 ↗
75. Strain-induced alignment in collagen gels10.1371/journal.pone.0005902 ↗
76. Dynamic alteration of poroelastic attributes as determinant membrane nanorheology for endocytosis of organ specific targeted gold nanoparticles10.1186/s12951-022-01276-1 ↗